Robillon J F, Sadoul J L, Jullien D, Morand P, Freychet P
Department of Internal Medicine, Endocrinology and Metabolism, Hôpital Pasteur, Centre Hospitalier Universitaire, Nice, France.
Diabete Metab. 1994 Sep-Oct;20(5):473-80.
The aim was to assess the presence of cardiomyopathic features in asymptomatic patients with Type 1 and Type 2 diabetes mellitus.
Fifty-two (27 Type 1; mean duration: 10.2 +/- 7.4 yr; 25 Type 2, mean duration: 6.5 +/- 4.4 yr) diabetic patients with no signs of ischaemic heart disease or high blood pressure were studied by noninvasive techniques: Holter ECG; Filtered-Amplified ECG (FAECG); Exercise ECG; Echocardiography (BD, TM) and Doppler evaluation of diastolic parameters. Twenty-four healthy subjects matched for age were studied as controls.
Holter ECG did not detect rhythm disturbances or features of silent ischaemia in either group of patients. With FAECG, at least one criterion of late ventricular potentials was found in 28% of Type 2 patients, vs 11% of Type 1 patients and 8.3% of control subjects. With exercise ECG, maximum oxygen uptake, anaerobic threshold, and workload performance were all significantly lower in Type 2 patients compared to control subjects. Echocardiography depicted a greater end diastolic interventricular septum thickness in Type 2 patients than in control subjects, with a trend toward left ventricular hypertrophy in 28% of Type 2 and 7.4% of Type 1 patients. Doppler echocardiography revealed a significant decrease in early diastolic peak filling rates (E) in diabetic patients as a whole group (Type 1 + Type 2) compared to controls. Late diastolic peak filling rates (A) were significantly higher in Type 2 patients than in their controls. The E/A ratio was significantly lower in diabetic patients (as a whole group) than in control subjects; this was accounted for mainly by a significant decrease of E/A in Type 2 patients compared to their controls.
Our major finding rests on the disclosure of abnormalities suggestive of cardiomyopathy in Type 2 diabetic patients with a relatively short duration of the known disease, while these alterations appeared in our study less prominent in Type 1 patients despite a longer duration of the disease. Among the various noninvasive techniques, FAECG and Doppler echocardiography used to detect late ventricular potentials and to assess left ventricular diastolic dysfunction, respectively, appear to be suitable tools.
旨在评估1型和2型糖尿病无症状患者中心肌病特征的存在情况。
对52例(27例1型,平均病程:10.2±7.4年;25例2型,平均病程:6.5±4.4年)无缺血性心脏病或高血压迹象的糖尿病患者采用无创技术进行研究:动态心电图;滤波放大心电图(FAECG);运动心电图;超声心动图(BD、TM)以及舒张参数的多普勒评估。选取24名年龄匹配的健康受试者作为对照。
动态心电图在两组患者中均未检测到心律失常或无症状性缺血特征。使用FAECG时,28%的2型患者发现至少一项晚期心室电位标准,而1型患者为11%,对照受试者为8.3%。使用运动心电图时,2型患者的最大摄氧量、无氧阈值和工作量表现均显著低于对照受试者。超声心动图显示,2型患者舒张末期室间隔厚度大于对照受试者,28%的2型患者和7.4%的1型患者有左心室肥厚倾向。多普勒超声心动图显示,与对照组相比,糖尿病患者(1型+2型)整个组的舒张早期峰值充盈率(E)显著降低。2型患者的舒张晚期峰值充盈率(A)显著高于其对照组。糖尿病患者(整个组)的E/A比值显著低于对照受试者;这主要是由于2型患者与对照组相比E/A显著降低所致。
我们的主要发现基于在已知疾病病程相对较短的2型糖尿病患者中发现提示心肌病的异常情况,而在我们的研究中,尽管1型患者病程较长,但这些改变似乎不那么明显。在各种无创技术中,分别用于检测晚期心室电位和评估左心室舒张功能障碍的FAECG和多普勒超声心动图似乎是合适的工具。